BioClinica Names Mukhtar Ahmed as eClinical President
News Apr 24, 2015
BioClinica®, Inc. has announced that Mukhtar Ahmed, a recognized business leader within the life sciences, healthcare and technology sectors, will join BioClinica on April 20th as President of its Global eClinical Business Unit.
Mr. Ahmed most recently served as Global Vice President at Oracle Corporation responsible for growing Global Consulting Services and leading the Life Sciences business toward transformative cloud platforms, big data solutions and digital medicine. During a career spanning more than 25 years in the healthcare research industry, Mr. Ahmed has held senior executive positions with multinational Contract Research Organizations and clinical informatics companies including Kendle, Parexel and Medidata.
"Mukhtar has an exemplary track record delivering significant business benefits and operational growth strategies within the clinical technology sector," BioClinica CEO John Hubbard said. "He has a deep understanding of our business and eClinical customers, making him the right leader to drive new levels of innovation and value in clinical development."
"BioClinica is an industry leader with a comprehensive product platform and technology-enabled services, and I look forward to expanding on this success," Ahmed said. "I'm honored and excited to take on a new role with an organization that has built a reputation for innovation and customer focus."
Mr. Ahmed is an industry advisor to a number of start-ups and mid-range private equity companies and is currently a board advisor for a European laboratory company. He has previously held board-level, non-executive posts with National Health Service primary care and strategic health trusts in the United Kingdom.
Mr. Ahmed is routinely an industry speaker on topics including scientific innovation, strategic outsourcing, business change management, and medical device and clinical technologies. He earned degrees including a B.S. in Applied Systems and an M.S. in Neurological Imaging from Brunel University, as well as an MBA and post graduate diploma in Computer Science from Buckinghamshire University College.
BioClinica will host its annual Trial Blazers Customer Conference in the Orlando, Florida area on May 5 and 6.
Huntsman Cancer Institute Joins National Clinical Trial Targeting AMLNews
Huntsman Cancer Institute (HCI) at the University of Utah (U of U) has been selected to participate in the Beat AML Master Trial, an innovative clinical trial sponsored by The Leukemia & Lymphoma Society (LLS). The clinical trial is testing several new targeted therapies for the treatment of patients with acute myeloid leukemia (AML). HCI is the only facility in the Mountain West offering this trial to AML patients.READ MORE
Study Extends Potential of Personalized Cell-based ImmunotherapiesNews
New methods developed for the study could be applied to devise personalized, cell-based immunotherapies for epithelial ovarian cancer or other types of tumorsREAD MORE